@article{b0a24bc04b034dccbedd2248dcb25df7,
title = "Use of dose–exposure–response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasis",
author = "M. Lebwohl and Langley, {R. G.} and Y. Zhu and H. Zhou and M. Song and Shen, {Y. K.} and {Parnell Lafferty}, K. and K. Reich",
note = "Funding Information: Funding sources This study was funded by Janssen Research & Development, LLC. The authors wish to thank Kristin Ruley Sharples, PhD, of Janssen Scientific Affairs, LLC, Spring House, PA and Cynthia Guzzo, MD, of Kelly Services, for their writing and editorial support in the preparation of this article. Publisher Copyright: {\textcopyright} 2019 European Academy of Dermatology and Venereology",
year = "2019",
month = nov,
day = "1",
doi = "10.1111/jdv.15668",
language = "English",
volume = "33",
pages = "2082--2086",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Wiley-Blackwell",
number = "11",
}
